ReviewCancers2026

PARP Inhibitors in Metastatic Prostate Cancer: Bridging Biomarker Complexity and Clinical Decision-Making Through a Pragmatic Treatment Framework.

Halima Abahssain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.